
 
 
 
 
 
 
 
 
 
 
   經濟部中央標準局員工消f合作社印製  3綱驟  號專利申請案 利範圍修正本(86年7月）  A8 B8 C8 D8  申請專利祀圍  1. 一種下式（I)化合物 Printed by the Central Bureau of Standards of the Ministry of Economic Affairs, printed by the Cooperative Society of the 3rd Class Patent No. Patent Application Scope of Amendment (July 86) A8 B8 C8 D8 Patent Application Siege 1. A compound of formula (I) 
 
 
 
 
 
 
 
 
 
 
   (I)  其中Z是選自下式的四氫哌喃基  RZ ft (I) wherein Z is a tetrahydropiperanyl group selected from the formula RZ ft 
 
 
 
 
 
 
 
 
 
 
   w  R .〇&lt; Ί7(b).  及其醫藥上可接受的鹽及溶劑化物（如水合物），其中R1代表氫，画素，羥基，Ci_4烷氧基或醯氧基；R2及R3可各獨立代表氫，Cu烷基或Cb4烷氧基C丨_4  L:\EXTA41\41881.DOC  本紙張尺度適用中國國家標準（CNS ) A4規格（21〇X：297公釐）  (請先閲讀背面之注意事項再填寫本頁)  *1T  S31644 六、申請專利範圍  8 88S ABCD  經濟部中央橾準局員工消費合作社印製  境基，或R2及R3共同與其相聯的碳原子代表C = 〇，c = s 或C3.8環烷基； R代表虱或CH^R7(此處R7是氳，幾基，c]_4燒氧基咬 0C0R8基團，其中^是^一烷基，或苯基或5_或6_元 異芳環（其含有一或多個選自氮、氧或硫之異原子），其 各爲未經取代，或爲一或多個選自鹵素，羥基，Γ 1 - 6現 基，Ci_6烷氧基或c^4烷氧羰基之原子或基團取代）； R5及R6可各獨立代表氫； η代表零或1 ; X及Υ可各獨立代表氧或CR9R10(此處R9及Rl〇可獨立代 表氫’ Cb6烷基’ Cb4烷氧基或Ci-4烷氧基¢^-4烷基， 或R9及R10共同與其相聯的碳原子代表C = 〇，c = S，c3 8環烷基或C^CHR11，此處Rii代表氫或^彳烷基）；或 在X或Y爲乳且η爲零時，-Y_cr2r3或_x_cr2r3可分 別代表-N = CR3 -或- NR12-CR2R3-(此處 CR2 及 R3 是 C = 0，而R12是Ci_4烷基’ COR13醯基，此處R13是c 1 - 6烷基）或在Y是氧且η是零時，X可代表CH基，此基係以 雙鍵聯於喊喃環上； R15代表氫，鹵素，疊氮基，羥基，Cl_6烷氧基（視需要 由1或2個羥基或其縮酮或1或2個烷氧基取代）， C3_6烯氧基，OCOR18基團（此處r18是芳基ci4烷氧 基，烷基或含一或二個雙键之Cb1()烷基）或Ci_6 烷氧羰基C1-4烷氧基，而R!6代表氫或RI5及r16共同與 其相聯的碳原子代表C = 0或C = CH2 ;  L:\EXTA41\41881.DOC  本紙張尺度適用中國國家搮準（CNS ) A4规格（21〇χ297公兼）  (請先聞讀背面之注意事項再填寫本頁)  -、11  申請專利範圍  A8 B8 C8 D8  R]7代表CH2R19，此處r19是氫 w代表氧或硫原子； 又基團（a)之虚線表示有時有另外的鍵存在。 .根據申請專利範圍第1 的基圏  ;而  項之式（I)化合物’其中Z是如  下 w R .〇 &lt; Ί7 (b). And its pharmaceutically acceptable salts and solvates (such as hydrates), where R1 represents hydrogen, pixel, hydroxyl, Ci_4 alkoxy or acetyloxy; R2 and R3 may Each independent representative hydrogen, Cu alkyl or Cb4 alkoxy C 丨 _4 L: \ EXTA41 \ 41881.DOC This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (21〇X: 297 mm) (please read first (Notes on the back and then fill out this page) * 1T S31644 VI. Patent application range 8 88S ABCD The Ministry of Economic Affairs Central Consortium Bureau Consumer Cooperative printed the environmental base, or R2 and R3 together with the associated carbon atom representative C = 〇, c = s or C3.8 cycloalkyl; R stands for lice or CH ^ R7 (where R7 is 氲, several groups, c] _4 alkoxy group bite 0C0R8 group, where ^ is ^ -alkyl, or phenyl Or a 5- or 6-membered heteroaromatic ring (which contains one or more heteroatoms selected from nitrogen, oxygen, or sulfur), each of which is unsubstituted, or one or more selected from halogen, hydroxyl, Γ 1 -6 present groups, atom or group substitution of Ci_6 alkoxy or c ^ 4 alkoxycarbonyl); R5 and R6 may independently represent hydrogen; η represents zero or 1; X and Υ may independently represent oxygen or CR9R10 ( Here R9 and Rl〇 can independently represent hydrogen 'Cb6 alkyl' Cb4 alkoxy or Ci-4 alkoxy ^ ^ -4 alkyl, or R9 and R10 together with the carbon atoms associated with it represents C = 〇, c = S , C3 8 cycloalkyl or C ^ CHR11, where Rii represents hydrogen or ^ 彳 alkyl); or when X or Y is milk and η is zero, -Y_cr2r3 or _x_cr2r3 may represent -N = CR3-or -NR12-CR2R3- (where CR2 and R3 are C = 0, and R12 is Ci_4 alkyl 'COR13 acetyl, where R13 is c 1-6 alkyl) or when Y is oxygen and η is zero, X May represent CH group, this group is connected to the ring with a double bond; R15 represents hydrogen, halogen, azido, hydroxy, Cl_6 alkoxy (if necessary from 1 or 2 hydroxyl or ketal or 1 or 2 alkoxy substitutions), C3_6 alkenoxy, OCOR18 group (where r18 is aryl ci4 alkoxy, alkyl or Cb1 () alkyl with one or two double bonds) or Ci_6 alkoxycarbonyl C1-4 alkoxy, and R! 6 represents hydrogen or RI5 and r16 together with the associated carbon atom represents C = 0 or C = CH2; L: \ EXTA41 \ 41881.DOC This paper size is applicable to Chinese national standards ( CNS) A4 specification (21〇297 and public) (Please read the notes on the back first (Fill in this page)-, 11 Patent scope A8 B8 C8 D8 R] 7 represents CH2R19, where r19 is hydrogen w represents oxygen or sulfur atom; and the dotted line of group (a) indicates that sometimes there are additional bonds. .According to the base of the first patent application; and the compound of formula (I) in the item, where Z is as follows 
 
 
 
 
 
 
 
 
 
 
   或 '〇  R Or '〇 R 
 
 
 
 
 
 
 
 
 
 
   CH—-CH二 i  〇 FT  {請先W讀背面之注意事項再填寫本頁)  其中x或γ之—是氧，而另—個是氧或CR9Rl0基團。  3·根據申請專利範圍第！或2項之式（1)化合物，其中η  零。  4·根據申請專利範圍第丨或2之式（1)化合物，其中X及Υ都 是氧而R2及R3獨立代表氫或Ci“烷基。  5_根據申請專利範圍第！或2項之式（1)化合物，其中又及丫 之一是氧’而另一個是CR9r1〇基團。  6·根據申請專利範圍第5項之式（1)化合物，其中R9代表氫  或C】_4燒基而Rl〇代表氫或(：119111〇基團代表c〇基，或 C = CHRU。  7.根據申請專利範圍第1或2項之式（1)化合物，其中X是  氧。  8_根據申請專利範圍第i或2項之式化合物，其中R i是  .:\HXT\41\41881.DOC  、1Τ  衄濟部中央榡準局員工消費合作社印製  本紙張JULii财s u家料（CNS ) 210乂^7公复  321644  C8  _______ D8  六、申請專利範圍  氫或羥基而R4是甲基。  9·根據申請專利範圍第！項之式（1)化合物，其中 CH—CH 2 i 〇 FT (please read the precautions on the back before filling this page) where x or γ-is oxygen, and the other is oxygen or CR9Rl0 group. 3. According to the scope of the patent application! Or a compound of formula (1) in item 2, wherein η is zero. 4. According to the formula (1) compound of the first or second patent application scope, wherein X and Υ are both oxygen and R2 and R3 independently represent hydrogen or Ci "alkyl. 5_ According to the formula of the patent application scope item 1 or 2 (1) Compounds in which one of them is oxygen and the other is a CR9r10 group. 6. A compound of formula (1) according to item 5 of the patent application scope, in which R9 represents hydrogen or C] _4 burning group and Rl〇 stands for hydrogen or (: 119111〇 group stands for c〇 group, or C = CHRU. 7. The compound of formula (1) according to item 1 or 2 of the patent application scope, where X is oxygen. 8_ According to the patent application scope The compound of formula i or item 2, wherein R i is.: \ HXT \ 41 \ 41881.DOC, 1Τ Printed paper of Juli Choi Susu Household Materials (CNS) 210 ~ ^ 7 Public reply 321644 C8 _______ D8 6. The scope of patent application is hydrogen or hydroxy and R4 is methyl. 9. According to the compound of formula (1) in item 1 of the scope of patent application, where 
 
 
 
 
 
 
 
 
 
 
   其中W是氧。  10·根據申請專利範圍第2項之式（〗）化合物，其係[丨R_ ( i  ^,3a^ ,4^ ,4a/? ,7^ ,7a^s8a/?)]8a-[[lS, 7R,9R]-2,8-  二氧-9 -曱基-4 -亞曱基-順-雙環[3.4.0]_壬_7_基-氧基-甲基]-4-甲醯基-4,4&amp;，5,6,7,7&amp;，8,8&amp;-八氫-7-甲基-3-(1-甲基乙基）-1，4 -亞甲基-S-吲噠省- 3a-(lH) -羧酸；及 其醫藥上可接受的鹽。  根據申請專利範圍第1項之式（〗）化合物，其係選自[丨R_  (1 «，3a/?，4 ，4ay5，7 /?，7a or，8a々）]8a-[(2,6 -二去氧-  經濟部中央標準局員工消費合作社印製  3,4-0 -異亞丙基卢-D_別卓哌喃糖基氧基）曱基]_4_甲 酿基-4,4a，5，6,7,7a，8,8a -八氫-7-甲基- 3_(1-甲基乙 基）-1,4-亞甲基-s-吲噠省_3a(iH)_羧酸；  [1R-(1 a，3a点，4 点，4a/?，7々，7a a，8a点）]8a-[[l S,4R， 7汉，911]-2,8-二氧-4,9-二曱基-順-雙環[3.4.0]-壬-7-基-氧基-甲基]-4 -曱醯基-4,4a,5，6,7,7a，8,8a-八氫-7-  甲基-3-(1-甲基乙基）4,4-亞甲基-s-p引噠省_3a(lH)-羧 酸；  L:\EXTVUVn881.DOC _ 4 -  本紙張从適用中國國家標準（CNS ) M綱^ (加χ π?公釐）  ^21644  A8 B8 C8 D8  申請專利範圍  6R?Rl(-2a73.a^4/?，4a^，7^，7aflr，8a/5)38a'[[1S54S5 其匕 ，—氧·4,6-二甲基-順-雙環[3.4.0]-壬-8--乳-甲基]-4-甲酿基.4,4a，5,6,7,7a，8,8a_M_7_  酸.-_(1'甲基乙基卜1，4-亞甲基-s“㈣省-3a(lH)-叛  [1R (1 ar,3a/?54/?54a^,7^,7aa，58a/?)]8a_[(253  氧4 〇 -丙基_^_D_哌喃甘露糖基氧基）甲基]_4_ 甲酿基4,4&amp;，5,6,7,7&amp;，8,8&amp;-八氫^_曱基-3_(1.甲基乙 基）]，仁亞甲基十旁連省_3a(iH)邊酸；  a，3a乃，4万，4a々，7々，7&amp;“，8&amp;万）]8&amp;_[(2 3_脱水 6去氧-4_〇_曱基-冷-D -哌喃甘露糖基氧基）曱基]-4-  甲醯基-4,4a，5,6,7,7a，8,8a-八氫-7-曱基-3-(1-甲基乙  基）·1，4-亞甲基_s叫丨噠省_3&amp;(1Η)_羧酸；  及其醫藥上可接受的鹽。  12'種製備根據申請專利範圍第1項之式（I)化合物之方 法，其包括  Ο)使式（II)化合物  (請先閲讀背面之注意事項再填寫本頁)  人  訂  ί  經濟部中央梂準局員工消費合作社印製  XH Where W is oxygen. 10. The compound of formula (〗) according to item 2 of the patent application scope, which is [丨 R_ (i ^, 3a ^, 4 ^, 4a /?, 7 ^, 7a ^ s8a /?)] 8a-[[lS , 7R, 9R] -2,8-dioxo-9-methyl-4-methylidene-cis-bicyclo [3.4.0] _non_7_yl-oxy-methyl] -4-carboxamide -4,4 &amp;, 5,6,7,7 &amp;, 8,8 &amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-S- Indah-3a- (lH) -carboxylic acid; and its pharmaceutically acceptable salts. According to the formula (〗) compound of the first item of the patent application scope, it is selected from [丨 R_ (1 «, 3a / ?, 4, 4ay5, 7 / ?, 7a or, 8a々)] 8a-[(2, 6 -Dideoxy-printed by 3,4-0 -isopropylidene-D_bezopiperanosyloxy) methyl] _4_methanyl-4, 4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3_ (1-methylethyl) -1,4-methylene-s-indap province_3a (iH) _Carboxylic acid; [1R- (1 a, 3a point, 4 point, 4a / ?, 7々, 7a a, 8a point)] 8a-[[l S, 4R, 7 Han, 911] -2,8- Dioxo-4,9-dimethyl-cis-bicyclo [3.4.0] -non-7-yl-oxy-methyl] -4-methyl-4,4a, 5,6,7,7a , 8,8a-octahydro-7-methyl-3- (1-methylethyl) 4,4-methylene-sp lead-free_3a (lH) -carboxylic acid; L: \ EXTVUVn881.DOC _ 4-This paper is from China National Standard (CNS) M class ^ (plus χ π? Mm) ^ 21644 A8 B8 C8 D8 Patent scope 6R? Rl (-2a73.a ^ 4 / ?, 4a ^, 7 ^, 7aflr, 8a / 5) 38a '[[1S54S5 its dagger, -oxy · 4,6-dimethyl-cis-bicyclo [3.4.0] -non-8--lactyl-methyl] -4-methyl Brewer. 4,4a, 5,6,7,7a, 8,8a_M_7_ acid .-_ (1'Methylethyl 1,4-methylene -s "㈣ 省 -3a (lH)-defect [1R (1 ar, 3a /? 54 /? 54a ^, 7 ^, 7aa, 58a /?)] 8a _ [(253 oxy4 〇-propyl _ ^ _ D _Piperanmannosyloxy) methyl] _4_carbofuran 4,4 &amp;, 5,6,7,7 &amp;, 8,8 &amp; -octahydro ^ _methyl-3_ (1.methylethyl )], Renmethylene decapentan province _3a (iH) citric acid; a, 3a is, 40,000, 4a々, 7々, 7 &amp; “, 8 &amp; million)] 8 &amp; _ [(2 3_ Dehydrated 6-deoxy-4_〇_methyl-cold-D-piperanmannosyloxy) methyl] -4-methylacetate-4,4a, 5,6,7,7a, 8,8a- Octahydro-7-methyl-3- (1-methylethyl) · 1,4-methylene_s called 丨 Da province_3 & (1Η) _carboxylic acid; and its pharmaceutically acceptable salts . 12 'methods for preparing the compound of formula (I) according to item 1 of the patent application, which includes Ο) compound of formula (II) (please read the precautions on the back before filling in this page) XH printed by the quasi-bureau employee consumer cooperative 
 
 
 
 
 
 
 
 
 
 
   YH (II)  L:\EXT\41\41881.DOC  本紙張尺度適用中國國家梂率（CNS ) A*規格（2丨〇 χ 297公簸）  A8 B8 C8 D8  申請專利範圍  (其中R1及R4如上文式（I)中之定義，Rp是羧基保護基， 而X及Y如上文式（I)中之定義，只是X及/或γ不能代表  C R9 R1 〇)反應形成所需的環系統，然後再除去羧基保護  基；  (b)製備Z是（a)基團、γ是氧、η是零、R2&amp;R3是氫、而 X是CH的式（I)化合物時，使式（VII)化合物  (請先閲讀背面之注意事項再填寫本頁) YH (II) L: \ EXT \ 41 \ 41881.DOC This paper scale is applicable to China ’s national frame rate (CNS) A * specifications (2 丨 〇χ 297 hectares) A8 B8 C8 D8 Patent application scope (where R1 and R4 are as above As defined in formula (I), Rp is a carboxyl protecting group, and X and Y are as defined in formula (I) above, except that X and / or γ cannot represent CR 9 R1)) The reaction forms the desired ring system, Then remove the carboxyl protecting group; (b) When preparing the compound of formula (I) where Z is (a) group, γ is oxygen, η is zero, R2 &amp; R3 is hydrogen, and X is CH, use formula (VII) Compound (please read the notes on the back before filling this page) 
 
 
 
 
 
 
 
 
 
 
   (VII)  訂  經濟部中央榡準局員工消費合作社印製  其中R21是CHO基團或其經保護的衍生物，Rp*經保護 的羧基，與二烷基二偶氮甲基膦酸酯反應；  (c)製備Z是（b)基團而W是氧的式（I)化合物時，是環化 式（VIII)化合物  L:\EXT\41\41881.DOC  本紙張用 t 關家；^ ( CNS ) A视(  申請專利範圍 (VII) Printed by the Employee Consumer Cooperative of the Central Bureau of Preservation of the Ministry of Economy where R21 is the CHO group or its protected derivative, Rp * protected carboxyl group, and reacts with dialkylbisazomethylphosphonate (c) When the compound of formula (I) where Z is (b) group and W is oxygen, it is the cyclized compound of formula (VIII) L: \ EXT \ 41 \ 41881.DOC This paper uses t Guanjia; ^ ( CNS) A video (Scope of patent application 
 
 
 
 
 
 
 
 
 
 
   R 15« •R J7a 16a (VIII) (其中 R15a，R16a&amp;Rl7a如上文式（I)tRl5，r16及r17  疋定義’或其經保護的衍生物，Rp是氫或羧基保護基， L是適里的離去基如烷基-或芳基磺醯氧基，而r2 2是氮 或〇 R疋如乙定義之基團），必要時再除去任何存在之保 護基： (d)製備W是硫的式（I)化合物時，是將式（Ιχ)化合物  (請先閲讀背面之注意事項再填寫本頁)  經濟部中央標率局員工消費合作社印製 R 15 «• R J7a 16a (VIII) (wherein R15a, R16a &amp; Rl7a are as defined in formula (I) tRl5, r16 and r17 above) or their protected derivatives, Rp is hydrogen or carboxyl protecting group, L is suitable In the leaving group such as alkyl- or arylsulfonyloxy, and r2 2 is nitrogen or 〇R group as defined in B), if necessary, remove any existing protecting groups: (d) Preparation W is For the sulfur compound of formula (I), it is the compound of formula (Ιχ) (please read the precautions on the back before filling out this page). Printed by the Employee Consumer Cooperative of the Central Standardization Bureau 
 
 
 
 
 
 
 
 
 
 
   ,15 R16 ,17 (IX)  r:R15，R16H17如上文式⑴中之定義)用 必要或期望時再作一或多種如下步驟處理： (i)除去任何保護基；  硫供體處  本紙張尺度逍用中國國家榡準（CNS )八4規格（21〇&gt;&lt;297公釐  321644 as  Βδ  C8  __ D8  六、申請專利範圍  (ii) 將一種式（I)化合物或其經保護的衍生物轉化成另— 種式（I)化合物；  (iii) 分離式（I)化合物，呈其醫藥上可接受的鹽形式。  13_ —種治療抗眞菌感染之醫藥組合物，其含有根據申請專  利範圍第1或2項之式（I)化合物，並與—或多種生理β上可 接受的載劑或賦形劑混合。  (請先聞讀背面之注意事項再填寫本頁)  經濟部中央標隼局員工消费合作社印裝  8  一涞 -紙 本  Μ \—/ S Ν C /IV _一準 榡 I家 -國 -囷 I中 用 一逋  一釐 公 7 9 2 , 15 R16, 17 (IX) r: R15, R16H17 as defined in the above formula (1), if necessary or desired, do one or more of the following steps: (i) remove any protecting groups; sulfur donor at the paper size Use the Chinese National Standard (CNS) VIII 4 specifications (21〇 &gt; &lt; 297mm 321644 as Βδ C8 __ D8 VI. Scope of patent application (ii) A compound of formula (I) or its protected derivatives Conversion into another compound of formula (I); (iii) Isolation of compound of formula (I) in the form of its pharmaceutically acceptable salt. 13_ — A pharmaceutical composition for the treatment of anti-mycobacterial infections, which contains The compound of formula (I) according to item 1 or 2 and mixed with one or more physiologically acceptable carriers or excipients. (Please read the precautions on the back before filling out this page) Central Standard Falcon, Ministry of Economic Affairs Bureau Staff Consumer Cooperative Printed 8 Yi Lai-Paper Μ \ — / S Ν C / IV _ 一准 榡 I 家-国-囷 I 用 一 逋 個 公 7 7 2 
 
 
 
 
 
 
 
 
 
 
 
